» Authors » Andrea Biagi

Andrea Biagi

Explore the profile of Andrea Biagi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 174
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Halasz G, Cattaneo M, Piepoli M, Biagi A, Romano S, Biasini V, et al.
J Am Heart Assoc . 2021 Aug; 10(16):e020776. PMID: 34387099
Background Early repolarization pattern (ERP) is considered a common training-related and benign ECG finding in young adult athletes. Few data exist on ERP in the pediatric athletes population. Therefore, we...
12.
Sticchi A, Cereda A, Toselli M, Esposito A, Palmisano A, Vignale D, et al.
Anatol J Cardiol . 2021 Jun; 25(6):376-379. PMID: 34100723
No abstract available.
13.
Halasz G, Sperti M, Villani M, Michelucci U, Agostoni P, Biagi A, et al.
J Med Internet Res . 2021 May; 23(5):e29058. PMID: 33999838
Background: Several models have been developed to predict mortality in patients with COVID-19 pneumonia, but only a few have demonstrated enough discriminatory capacity. Machine learning algorithms represent a novel approach...
14.
Vergara P, Rossi L, Biagi A, Falasconi G, Pannone L, Zanni A, et al.
Minerva Med . 2021 Apr; 114(2):185-190. PMID: 33913658
Background: Cardiovascular comorbidities are a common cause of death in COVID-19 and the aim of this study is to evaluate the effect of comorbidities on mortality in COVID-19 patients. Methods:...
15.
Scoccia A, Gallone G, Cereda A, Palmisano A, Vignale D, Leone R, et al.
Atherosclerosis . 2021 Apr; 328:136-143. PMID: 33883086
Background And Aims: The potential impact of coronary atherosclerosis, as detected by coronary artery calcium, on clinical outcomes in COVID-19 patients remains unsettled. We aimed to evaluate the prognostic impact...
16.
Giannini F, Toselli M, Palmisano A, Cereda A, Vignale D, Leone R, et al.
J Cardiovasc Comput Tomogr . 2021 Mar; 15(5):421-430. PMID: 33744175
Background: Coronavirus disease 2019 (COVID-19) has spread worldwide determining dramatic impacts on healthcare systems. Early identification of high-risk parameters is required in order to provide the best therapeutic approach. Coronary,...
17.
Esposito A, Palmisano A, Toselli M, Vignale D, Cereda A, Rancoita P, et al.
Eur Radiol . 2020 Dec; 31(6):4031-4041. PMID: 33355697
Objectives: Enlarged main pulmonary artery diameter (MPAD) resulted to be associated with pulmonary hypertension and mortality in a non-COVID-19 setting. The aim was to investigate and validate the association between...
18.
Rossi L, Malagoli A, Biagi A, Zanni A, Sticozzi C, Comastri G, et al.
Infection . 2020 Nov; 49(2):287-294. PMID: 33222020
Association of renin-angiotensin system inhibitors with risk of death in patients with hypertension (HTN) and coronavirus disease 2019 (COVID-19) is not well characterized. The aim of this study was to...
19.
Perrone F, Biagi A, Facchinetti F, Bozzetti F, Ramelli A, Vezzani A, et al.
Oncol Lett . 2020 Sep; 20(5):194. PMID: 32952663
Thromboembolic events are frequent in patients with cancer, commonly involving the venous and pulmonary circulation. The arterial system is rarely implicated in embolism and, when involved, a cardiogenic origin should...
20.
Biagi A, Rossi L, Malagoli A, Zanni A, Sticozzi C, Comastri G, et al.
J Med Virol . 2020 Jun; 92(11):2718-2724. PMID: 32515500
Studies have described clinical features of patients with coronavirus disease (COVID-19). However, limited data concerning the clinical characteristics of the Italian deaths are available. We aim to describe the clinical...